Wednesday - October 04, 2023

Category Archives: Pharmaceuticals & Biotech

NeurAxis PENFS IB-Stim Technology: A Drug-Free, Non-Invasive Way To Effectively Treat Pediatric Functional Abdominal Pain Associated With IBS ($NRXS)

NeurAxis Inc. (NYSE-Amer: NRXS) proves that a smallcap biotech can deliver best-in-market care. That’s more than great news for NRXS from a revenue perspective and for its patients from a treatment point of view. It can also be excellent news for … Continue reading →

Laboratory Freezers Market Projected to Reach $5.7 Billion by 2026 | MarketsandMarkets™ Study

Browse 274 market data Tables and 52 Figures spread through 291 Pages and in-depth TOC on “Laboratory Freezers Market by Product(Cryopreservation, Plasma Freezer, ExplosionProof Freezer, Enzyme Freezer, Ultra-Low Freezer, Blood Bank Refrigerator, Pharmacy Refrigerator, Chromatography Refrigerator), End User(Hospitals) – Global … Continue reading →

Vaccine Adjuvants Market Poised for Remarkable $1.2 Billion Milestone by 2028 | MarketsandMarkets™ Study

Browse 200 market data Tables and 45 Figures spread through 230 Pages and in-depth TOC on “Vaccine Adjuvants Market by Product (Emulsions, Pathogen, Saponin, Particulate), Route of administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Type ( Human vaccine , Veterinary … Continue reading →

Breast Cancer Biomarker Market Size for 7MM was approximately USD 7,000 Million in 2022, estimates DelveInsight

“The Breast Cancer Biomarker Market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- Breast Cancer Biomarker pipeline products will significantly revolutionize the Breast Cancer Biomarker market dynamics” … Continue reading →

Metastatic Prostate Cancer Market Size in the 7MM was ~USD 6400 million in 2022, Estimates DelveInsight

“The Metastatic Prostate Cancer market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- Metastatic Prostate Cancer pipeline products will significantly revolutionize the Metastatic Prostate Cancer market dynamics” … Continue reading →

HER2-Positive Breast Cancer Market Size in the US was approximately USD 1,600 Million in 2022, Estimates DelveInsight

“The HER2-Positive Breast Cancer market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- HER2-Positive Breast Cancer pipeline products will significantly revolutionize the HER2-Positive Breast Cancer market dynamics” … Continue reading →

Non-Small Cell Lung Cancer Market Size in the 7MM is expected to change in the study period 2019-2032, estimates DelveInsight

“The Non-Small Cell Lung Cancer market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- Non-Small Cell Lung Cancer pipeline products will significantly revolutionize the Non-Small Cell Lung … Continue reading →

Multiple Myeloma Market Size in the 7MM was approximately USD 20,000 Million in 2022, Estimates DelveInsight

“The Multiple Myeloma market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- Multiple Myeloma pipeline products will significantly revolutionize the Multiple Myeloma market dynamics”   The Multiple … Continue reading →

Acute Myeloid Leukemia Market Size in the 7MM was approximately USD 1,300 million in 2020, estimates DelveInsight

“The Acute Myeloid Leukemia market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- Acute Myeloid Leukemia pipeline products will significantly revolutionize the Acute Myeloid Leukemia market dynamics” … Continue reading →